New York State Common Retirement Fund Sells 10,272 Shares of Humana Inc. (NYSE:HUM)

New York State Common Retirement Fund cut its position in shares of Humana Inc. (NYSE:HUM) by 5.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 185,906 shares of the insurance provider’s stock after selling 10,272 shares during the period. New York State Common Retirement Fund’s holdings in Humana were worth $85,110,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of HUM. California Public Employees Retirement System grew its position in Humana by 2.6% during the 4th quarter. California Public Employees Retirement System now owns 476,938 shares of the insurance provider’s stock worth $218,347,000 after acquiring an additional 12,300 shares during the last quarter. Stock Yards Bank & Trust Co. grew its position in Humana by 12.8% during the 4th quarter. Stock Yards Bank & Trust Co. now owns 20,103 shares of the insurance provider’s stock worth $9,203,000 after acquiring an additional 2,285 shares during the last quarter. Significant Wealth Partners LLC bought a new position in Humana during the 4th quarter worth approximately $248,000. Duality Advisers LP bought a new position in Humana during the 4th quarter worth approximately $5,546,000. Finally, Cetera Trust Company N.A bought a new position in Humana during the 4th quarter worth approximately $28,000. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Up 0.2 %

HUM stock traded up $0.77 on Tuesday, reaching $326.07. 502,904 shares of the company traded hands, compared to its average volume of 1,972,696. Humana Inc. has a one year low of $299.23 and a one year high of $541.21. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.59 and a quick ratio of 1.59. The company has a market cap of $39.34 billion, a P/E ratio of 16.44, a price-to-earnings-growth ratio of 1.92 and a beta of 0.45. The firm has a fifty day simple moving average of $330.09 and a 200-day simple moving average of $399.70.

Humana (NYSE:HUM) last posted its quarterly earnings data on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.87). The company had revenue of $26.46 billion for the quarter, compared to the consensus estimate of $25.47 billion. Humana had a net margin of 2.34% and a return on equity of 19.44%. The firm’s quarterly revenue was up 17.9% on a year-over-year basis. During the same period last year, the business earned $1.62 EPS. Research analysts anticipate that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date is Friday, June 28th. Humana’s payout ratio is 17.86%.

Insiders Place Their Bets

In other Humana news, Director Jorge S. Mesquita bought 545 shares of Humana stock in a transaction on Tuesday, February 20th. The stock was acquired at an average price of $367.09 per share, with a total value of $200,064.05. Following the acquisition, the director now owns 2,578 shares in the company, valued at $946,358.02. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.29% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on HUM. StockNews.com lowered Humana from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 26th. The Goldman Sachs Group reduced their price target on Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. TD Cowen dropped their price objective on Humana from $427.00 to $396.00 and set a “buy” rating for the company in a report on Tuesday, April 2nd. Jefferies Financial Group dropped their price objective on Humana from $411.00 to $381.00 and set a “buy” rating for the company in a report on Monday. Finally, Bank of America reiterated a “neutral” rating and issued a $342.00 price objective (down previously from $470.00) on shares of Humana in a report on Tuesday, April 2nd. Eleven investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $454.63.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.